Verlytix

Verlytix is a specialized contract research organization (CRO) providing high-quality bioanalytical services to the pharmaceutical and biotechnology industries. The company focuses on the application of advanced mass spectrometry and ligand binding assays to support drug discovery and development programs. Their expertise spans pharmacokinetic (PK) analysis, pharmacodynamic (PD) assessment, biomarker validation, and immunogenicity testing. By leveraging deep scientific knowledge and state-of-the-art technology, Verlytix helps clients navigate complex regulatory requirements and accelerate the transition of therapeutic candidates from preclinical stages to clinical trials. The firm is led by industry veterans with extensive experience in bioanalytical strategy and execution for both small and large molecule therapeutics.